Vir Biotechnology (VIR) Other Operating Expenses (2018 - 2025)

Vir Biotechnology has disclosed Other Operating Expenses across 7 years of filings, most recently posting $26000.0 for Q4 2025.

• Other Operating Expenses for Q4 2025 came in at $26000.0, up 100.8% year-over-year; the trailing twelve-month figure through Mar 2026 was -$146000.0 (down 100.41% YoY), and the FY2025 annual result was -$156000.0, down 100.44% from the prior year.
• Other Operating Expenses came in at $26000.0 for Q4 2025 at Vir Biotechnology, up from -$11000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $90.1 million in Q1 2022 to a low of -$3.3 million in Q4 2024.
• The 5-year median for Other Operating Expenses is $5.4 million (2023), against an average of $13.9 million.
• Across the five-year window, Other Operating Expenses soared 2340.65% in 2022 and plunged 190.91% in 2025, its largest moves.
• Vir Biotechnology's Other Operating Expenses stood at $56.9 million in 2021, then sank by 89.46% to $6.0 million in 2022, then fell by 6.29% to $5.6 million in 2023, then slumped by 158.02% to -$3.3 million in 2024, then soared by 100.8% to $26000.0 in 2025.
• The last three Other Operating Expenses figures came in at $26000.0 (Q4 2025), -$11000.0 (Q3 2025), and -$161000.0 (Q2 2025), per Business Quant data.